Cancer mortality in Down syndrome in California

Cancer in Down syndrome (DS) is characterized by a well known and marked excess of leukaemia whereas few cohort studies are available on solid tumours in this population. Objective: To study the cancer mortality of DS in California. Study group: 16,808 DS cases (contributing 129,076 person-years) among 210,155 persons having received annual evaluations from the California Department of Developmental Services over the period 1988-2002 were followed. Methods: Cancer mortality in DS was compared with the Californian general population using age-standardized mortality ratios (SMRs) computed for various cancer sites (ICD-9 codes 140-208). Results: An excess of overall cancer mortality (SMR 2.6, 95% CI 2.0-3.2) was found with overall SMR for neoplasms of the lymphatic and hematopoietic system at 10.3 (CI 7.5-13.9) [lymphomas: 3.7 (1.3-8.0), lymphoid leukemias: 27.6 (17.5-41.4), other specified leukemias: 51.1 (1.3-285.0) and unspecified leukemias: 25.4 (13.1-44.3)]. Liver [5.6 (1.8-13.1)] and testicular cancer [12.5 (1.5-45.1) were also more common in DS. No cancer deaths from lip, oral cavity, or pharynx were reported in DS. Other sites showed no significant differences. Excluding neoplasms of lymphatic and hematopoietic systems, the SMR for remaining cancers was 1.2 (0.8-1.7). Conclusion: Our findings do not support the hypothesis of a decreased risk of solid tumours in general in DS and confirm increased risk of testis and liver cancers. Further studies taking into account hormonal and genetic factors are needed to better understand the specific tumour profile in DS.

[1]  A. Ugazio,et al.  Immunological features of Down's syndrome: a review. , 2008, Journal of intellectual disability research : JIDR.

[2]  R. Hussain,et al.  The profile and incidence of cancer in Down syndrome. , 2007, Journal of intellectual disability research : JIDR.

[3]  A. Sasco,et al.  Aspects of Digestive Tract Tumors in Down Syndrome: A Literature Review , 2006, Digestive Diseases and Sciences.

[4]  Eero Pukkala,et al.  Cancer incidence of persons with down syndrome in Finland: A population‐based study , 2006, International journal of cancer.

[5]  S. Day,et al.  Mortality and causes of death in persons with Down syndrome in California. , 2005, Developmental medicine and child neurology.

[6]  M. Goldacre,et al.  Cancers and immune related diseases associated with Down’s syndrome: a record linkage study , 2004, Archives of Disease in Childhood.

[7]  P. Vyas,et al.  Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. , 2004, Blood.

[8]  A. Sasco,et al.  Are solid tumours different in children with Down's syndrome? , 2003, International journal of cancer.

[9]  James M. Eldred,et al.  The DNA sequence of human chromosome 7 , 2003, Nature.

[10]  J. Park,et al.  Loss of heterozygosity on the long arm of chromosome 21 in non-small cell lung cancer. , 2003, The Annals of thoracic surgery.

[11]  Sven Cnattingius,et al.  Mortality and cancer incidence among individuals with Down syndrome. , 2003, Archives of internal medicine.

[12]  S. Rasmussen,et al.  Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study , 2002, The Lancet.

[13]  B. Modan,et al.  Incidence of leukemia and other cancers in Down syndrome subjects in Israel , 2001, International journal of cancer.

[14]  H. Hasle.  Pattern of malignant disorders in individuals with Down's syndrome. , 2001, The Lancet. Oncology.

[15]  M. Hattori,et al.  The DNA sequence of human chromosome 21 , 2000, Nature.

[16]  H. Leonard,et al.  Survival of infants born with Down's syndrome: 1980-96. , 2000, Paediatric and perinatal epidemiology.

[17]  H. Hasle,et al.  Risks of leukaemia and solid tumours in individuals with Down's syndrome , 2000, The Lancet.

[18]  P. van Damme,et al.  Hepatitis B and C in institutions for individuals with intellectual disability. , 1999, Journal of intellectual disability research : JIDR.

[19]  T. Shibahara,et al.  Frequent allelic loss/imbalance on the long arm of chromosome 21 in oral cancer: evidence for three discrete tumor suppressor gene loci. , 1999, Oncology reports.

[20]  G. Sutton,et al.  Trisomy 21 associated with ovarian dysgerminoma. , 1999, Gynecologic oncology.

[21]  M. Nishi,et al.  A tumor profile in Down syndrome. , 1998, American journal of medical genetics.

[22]  A. Sasco,et al.  An excess of testicular germ cell tumors in down's syndrome , 1997, Cancer.

[23]  A. Alberti,et al.  Basal body temperature curves and endocrine pattern of menstrual cycles in Down syndrome. , 1996, Gynecological Endocrinology.

[24]  Eyman Rk,et al.  Life expectancy of persons with Down syndrome. , 1991 .

[25]  T Scholl,et al.  Leukemia and other Cancers, Anomalies and Infections as Causes of Death in Down's Syndrome in the United States during 1976 , 1982, Developmental medicine and child neurology.

[26]  J. Øster,et al.  MORTALITY AND LIFE‐TABLE IN DOWN'S SYNDROME , 1975, Acta paediatrica Scandinavica.

[27]  R. Barber,et al.  OXFORD SURVEY OF CHILDHOOD CANCERS; PROGRESS REPORT II. , 1964, Monthly bulletin of the Ministry of Health and the Public Health Laboratory Service.

[28]  R. Doll,et al.  The Mortality from Leukaemia and Other Cancers Among Patients with Down's Syndrome (Mongols) and Among their Parents , 1962, British Journal of Cancer.

[29]  M. Thun,et al.  Tobacco smoke and involuntary smoking. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.

[30]  J. Merrick,et al.  Cancer incidence in persons with Down syndrome in Israel. , 2002, Down's syndrome, research and practice : the journal of the Sarah Duffen Centre.

[31]  V. Beral,et al.  Mortality and cancer incidence in persons with Down's syndrome, their parents and siblings. , 2001 .

[32]  A. Sasco,et al.  [Breast cancer in women with trisomy 21]. , 2001, Bulletin de l'Academie nationale de medecine.

[33]  R. Eyman,et al.  Life expectancy of persons with Down syndrome. , 1991, American journal of mental retardation : AJMR.